FLOT1 and prostate carcinoma: Combined with the results indicating the importance of flotillin-1 palmitoylation for sustained IGF-1 signaling, these data suggest that the palmitoylation status of flotillin-1 at the endoplasmic reticulum and the plasma membrane affects proliferation and metastatic potential of prostate cancer cells [56].